These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 22319594)

  • 1. Benzo[a]pyrene, aflatoxine B₁ and acetaldehyde mutational patterns in TP53 gene using a functional assay: relevance to human cancer aetiology.
    Paget V; Lechevrel M; André V; Goff JL; Pottier D; Billet S; Garçon G; Shirali P; Sichel F
    PLoS One; 2012; 7(2):e30921. PubMed ID: 22319594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aflatoxin B1-induced TP53 mutational pattern in normal human cells using the FASAY (Functional Analysis of Separated Alleles in Yeast).
    Paget V; Sichel F; Garon D; Lechevrel M
    Mutat Res; 2008 Oct; 656(1-2):55-61. PubMed ID: 18725321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetaldehyde-induced mutational pattern in the tumour suppressor gene TP53 analysed by use of a functional assay, the FASAY (functional analysis of separated alleles in yeast).
    Paget V; Lechevrel M; Sichel F
    Mutat Res; 2008 Mar; 652(1):12-9. PubMed ID: 18242117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 mutation spectrum and load: the generation of hypotheses linking the exposure of endogenous or exogenous carcinogens to human cancer.
    Hussain SP; Harris CC
    Mutat Res; 1999 Jul; 428(1-2):23-32. PubMed ID: 10517975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzo[a]pyrene-induced mutagenesis of p53 hot-spot codons 248 and 249 in human hepatocytes.
    Cherpillod P; Amstad PA
    Mol Carcinog; 1995 May; 13(1):15-20. PubMed ID: 7766306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogens.
    Puisieux A; Lim S; Groopman J; Ozturk M
    Cancer Res; 1991 Nov; 51(22):6185-9. PubMed ID: 1933877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linking environmental carcinogen exposure to TP53 mutations in human tumours using the human TP53 knock-in (Hupki) mouse model.
    Kucab JE; Phillips DH; Arlt VM
    FEBS J; 2010 Jun; 277(12):2567-83. PubMed ID: 20553493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutability of p53 hotspot codons to benzo(a)pyrene diol epoxide (BPDE) and the frequency of p53 mutations in nontumorous human lung.
    Hussain SP; Amstad P; Raja K; Sawyer M; Hofseth L; Shields PG; Hewer A; Phillips DH; Ryberg D; Haugen A; Harris CC
    Cancer Res; 2001 Sep; 61(17):6350-5. PubMed ID: 11522624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzene-induced mutational pattern in the tumour suppressor gene TP53 analysed by use of a functional assay, the functional analysis of separated alleles in yeast, in human lung cells.
    Billet S; Paget V; Garçon G; Heutte N; André V; Shirali P; Sichel F
    Arch Toxicol; 2010 Feb; 84(2):99-107. PubMed ID: 19862502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro recapitulating of TP53 mutagenesis in hepatocellular carcinoma associated with dietary aflatoxin B1 exposure.
    Besaratinia A; Kim SI; Hainaut P; Pfeifer GP
    Gastroenterology; 2009 Sep; 137(3):1127-37, 1137.e1-5. PubMed ID: 19524575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of TP53 mutation spectra reveals the fingerprint of the potent environmental carcinogen, aristolochic acid.
    Hollstein M; Moriya M; Grollman AP; Olivier M
    Mutat Res; 2013; 753(1):41-49. PubMed ID: 23422071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 mutations in benzo(a)pyrene-exposed human p53 knock-in murine fibroblasts correlate with p53 mutations in human lung tumors.
    Liu Z; Muehlbauer KR; Schmeiser HH; Hergenhahn M; Belharazem D; Hollstein MC
    Cancer Res; 2005 Apr; 65(7):2583-7. PubMed ID: 15805253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mutations of tumor suppressor gemne TP53 in tobacco smoke-associated tumors].
    Szyfter K; Kiwerska K; Rydzanicz M; Kruszyna Ł; Zemleduch T; Jagodziński P
    Przegl Lek; 2009; 66(10):603-7. PubMed ID: 20301891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutagenicity of acrylamide and glycidamide in human TP53 knock-in (Hupki) mouse embryo fibroblasts.
    Hölzl-Armstrong L; Kucab JE; Moody S; Zwart EP; Loutkotová L; Duffy V; Luijten M; Gamboa da Costa G; Stratton MR; Phillips DH; Arlt VM
    Arch Toxicol; 2020 Dec; 94(12):4173-4196. PubMed ID: 32886187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers.
    Pfeifer GP; Denissenko MF; Olivier M; Tretyakova N; Hecht SS; Hainaut P
    Oncogene; 2002 Oct; 21(48):7435-51. PubMed ID: 12379884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterising Mutational Spectra of Carcinogens in the Tumour Suppressor Gene
    Hölzl-Armstrong L; Kucab JE; Korenjak M; Luijten M; Phillips DH; Zavadil J; Arlt VM
    Methods Protoc; 2019 Nov; 2(4):. PubMed ID: 31766274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between exposure to aflatoxin, mutation in TP53, infection with hepatitis B virus, and occurrence of liver disease in a selected population in Hyderabad, India.
    Anitha S; Raghunadharao D; Waliyar F; Sudini H; Parveen M; Rao R; Kumar PL
    Mutat Res Genet Toxicol Environ Mutagen; 2014 May; 766():23-8. PubMed ID: 24657665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of TP53 mutations by DHPLC and sequencing in brain tumours from patients with an occupational exposure to pesticides or organic solvents.
    Loyant V; Jaffré A; Breton J; Baldi I; Vital A; Chapon F; Dutoit S; Lecluse Y; Loiseau H; Lebailly P; Gauduchon P
    Mutagenesis; 2005 Sep; 20(5):365-73. PubMed ID: 16105905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylated CpG dinucleotides are the preferential targets for G-to-T transversion mutations induced by benzo[a]pyrene diol epoxide in mammalian cells: similarities with the p53 mutation spectrum in smoking-associated lung cancers.
    Yoon JH; Smith LE; Feng Z; Tang M; Lee CS; Pfeifer GP
    Cancer Res; 2001 Oct; 61(19):7110-7. PubMed ID: 11585742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic aflatoxin B1-DNA adducts and TP53 mutations in patients with hepatocellular carcinoma despite low exposure to aflatoxin B1 in southern Japan.
    Shirabe K; Toshima T; Taketomi A; Taguchi K; Yoshizumi T; Uchiyama H; Harimoto N; Kajiyama K; Egashira A; Maehara Y
    Liver Int; 2011 Oct; 31(9):1366-72. PubMed ID: 21745313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.